Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

130
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
04/09/2014 04/10/2014 04/11/2014 04/14/2014 04/15/2014 Date
73.5(c) 74.2(c) 72.9(c) 73.85(c) 73.55(c) Last
3 272 939 3 759 960 5 218 772 5 029 198 4 347 155 Volume
-0.27% +0.95% -1.75% +1.30% -0.41% Change
More quotes
Company
Novartis is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical products (56.7%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal... 
Surperformance© rating of Novartis AG
Trading Rating : Investor Rating :
More about the company
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 59 104 M
EBIT 2014 13 426 M
Net income 2014 10 551 M
Debt 2014 4 553 M
Yield 2014 3,26%
Sales 2015 60 505 M
EBIT 2015 14 186 M
Net income 2015 11 110 M
Debt 2015 2 916 M
Yield 2015 3,47%
PER 2014 18,99
PER 2015 17,45
EV / Sales 2014 3,91x
EV / Sales 2015 3,79x
Capitalization 226 285 M
More Financials
Latest news on NOVARTIS AG
2d ago NOVARTIS : Sandoz demonstrates innovation strength at "Long Night of Research"
2d ago NOVARTIS : Appoints PharmaVentures as Advisors on the Future of its UK Horsham S..
2d ago CELGENE : Assigned Patent
2d ago GSK faces criminal bribery investigation in Poland
3d ago NOVARTIS : Farma to Implement OneKey (Cegedim Relationship Management)
6d ago NOVARTIS : Oxford BioMedica Announces Preliminary Results for the Year Ended 31 ..
6d agoDJZurich Stocks See Gains
6d ago NOVARTIS : Through the art of makeup, people with rare pituitary disorders now h..
6d ago NOVARTIS : French antitrust watchdog probes Roche and Novartis over eye drug
6d ago NOVARTIS : Roche says did not collude with Novartis to restrict competition
6d ago Patent Issued for Cyclosporin Analogues
7d ago NOVARTIS : data on 19 compounds at AACR highlight strong cancer pipeline across ..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
Novartis AG : Income Statement Evolution
More Financials
EPS Revisions
Novartis AG : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF